AXSM vs JPM Stock Comparison

JPM currently leads AXSM in this stock comparison, with AIQ scores of 65 vs 47. The clearest difference is momentum, while AXSM has the stronger value profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 18 points
AXSM
Healthcare
vs
JPM
Financial Services
AXSM
Axsome Therapeutics, Inc.
Price
$142
Day move
-1.86%
AIQ Score
47/100
Best edge
Value
Sector
Healthcare
JPM
JPMorgan Chase & Co.
Leads
Price
$346
Day move
+0.98%
AIQ Score
65/100
Best edge
Momentum
Sector
Financial Services

What is the main difference between AXSM and JPM?

JPM leads the current stock comparison as JPMorgan Chase & Co., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Axsome Therapeutics, Inc. vs JPMorgan Chase & Co.

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Financial Services· Coverage 65/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

JPM leads

JPM leads by 18 AIQ points, primarily on Momentum and Risk Resilience, and the lead has widened from 12 points over 30 sessions. Wall Street currently favors AXSM on target upside.

Competitive: 3 of 6 evidence groups support JPM, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Strengthening
AXSM

Axsome Therapeutics, Inc.

AIQ Score
47/100
AIQ Edge Score
3/10
JPM

JPMorgan Chase & Co.

Leads
AIQ Score
65/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors JPM over AXSM, 65 versus 47 as of Nov 15, 2026. JPM's advantage is driven primarily by stronger momentum and risk resilience, while AXSM holds the stronger value profile. JPM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors AXSM. 3 of 6 covered evidence groups favor JPM today, and the comparison is rated Competitive on stability: only 3 of 6 covered evidence groups agree. JPM lead: Strengthening — the AIQ differential moved from 12 to 18 points over 30 sessions.

Compare Axsome Therapeutics, Inc. and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

AXSM
+310.1%
JPM
+138.4%

Total return comparison

Growth of $10,000, distributions reinvested

AXSM $41,010 · JPM $23,841

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare AXSM and JPM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

AXSM advantage
0
JPM advantage
  • Value65 vs 10
    AXSM +55
  • Momentum24 vs 70
    JPM +46
  • Risk Resilience57 vs 87
    JPM +30
  • Quality57 vs 86
    JPM +29

3 of 6 evidence groups favor JPM. JPM’s edge is concentrated in momentum and risk resilience; AXSM keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

AXSM0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 4 active signals are unchanged.

JPM0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

JPM's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — AXSM and JPM both carry a full feed there.

The central trade-off

JPM (JPMorgan Chase & Co.): the stronger current systematic profile, led by momentum and risk resilience.

AXSM (Axsome Therapeutics, Inc.): the counter-case, on value, fundamentals, valuation — but at materially higher volatility, 53.2% against 27.4%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

JPM

JPM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AXSM

AXSM on combined revenue and EPS growth.

Value

AXSM

AXSM on the peer-relative Value factor, by 55 points.

Momentum

JPM

JPM on the Momentum factor, by 46 points.

Lower downside

JPM

JPM on Risk Resilience, by 30 points.

Analyst upside

AXSM

AXSM on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors JPM, analyst targets favor AXSM. That disagreement is the most useful thing on this page.

MeasureAXSMJPMNote
Implied upside to target+83.6%+7.8%AXSM has more room
Target dispersion+21.9%+30.3%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2226Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor JPM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreJPM47 vs 65
FundamentalsAXSMon balancerevenue growth 18.9% vs -7.6%; EPS growth 74.7% vs -27.6%; TTM ROE -12.2% vs 4.1%; gross margin 93.2% vs 63.2%; operating margin -17.7% vs 28.2% — AXSM takes 3 of 5 decided legs, not all of them
ValuationAXSMValue 65 vs 10
TechnicalsJPMPrice vs 50-day -17.4% vs 1.7%; vs 200-day -28.1% vs 6.6%
Risk ResilienceJPMRisk Resilience 57 vs 87
Analyst expectationsAXSMTarget upside 83.6% vs 7.8%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AXSM and JPM and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 18 points. (supports the conclusion holding)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on JPM.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

JPM lead: Strengthening — the AIQ differential moved from 12 to 18 points over 30 sessions.

May 27AXSM leads above the line · JPM leads belowNov 13
Today
JPM +18
47 vs 65
7 sessions ago
JPM +17
47 vs 64
30 sessions ago
JPM +12
51 vs 63
90 sessions ago
JPM +3
61 vs 64

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

AXSMConflicted

1 bullish / 2 bearish / 1 neutral, conflicted

Only AXSM

  • Death Cross Active — bearish, trend, long horizon (14.93%)
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.51%)
  • Downtrend Structure Active — bearish, trend, long horizon
JPMConflicted

6 bullish / 1 bearish / 1 neutral, conflicted

Only JPM

  • Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
  • Golden Cross Active — bullish, trend, long horizon (4.79%)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.65x)
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Both carry 1 more signal that do not separate them: MACD Histogram Expanding Bullish.

JPM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

AXSMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.86%, AIQ 0 points).

JPMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.98%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1AXSM closes the Momentum gap — currently 46 points behind, the largest single contributor to JPM's edge.
  2. 2AXSM's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3JPM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AXSM leads on balance
MetricAXSMJPM
Revenue growth (YoY)18.9%-7.6%
EPS growth (YoY)74.7%-27.6%
Gross margin93.2%63.2%
Operating margin-17.7%28.2%
Return on equity (TTM)-12.2%4.1%
Debt to equity2.073.32

Performance

JPM leads 5 of 6 windows
MetricAXSMJPM
1 week (5 sessions)7%3.5%
1 month (20 sessions)-9.8%1.9%
3 months (63 sessions)-34.5%-4.1%
6 months (126 sessions)-37.8%16.2%
Year to date-22.4%7.4%
1 year (252 sessions)0.6%8%

Technicals

JPM has the stronger structure
MetricAXSMJPM
RSI (14)40.856.1
ADX (14)37.218
Price vs 50-day-17.4%1.7%
Price vs 200-day-28.1%6.6%
Volatility (1M, annualized)53.2%27.4%

Risk

JPM is the more resilient
MetricAXSMJPM
Beta0.660.78
Sharpe ratio0.20.44
Sortino ratio0.340.61
Max drawdown-49.1%-15.5%
Current drawdown-44.5%-5.2%
Annualized volatility45.8%22.7%
Value at risk (95%)-4.1%-2.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, AXSM or JPM?

On the Algovestiq AIQ Score, JPM is the stronger of the two as of Nov 15, 2026, scoring 65 against AXSM's 47. The edge comes from momentum and risk resilience. AXSM is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is AXSM or JPM the better buy right now?

JPM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor JPM over AXSM?

The composite weights Quality, Value, Momentum and Risk Resilience. AXSM leads Value by 55 points; JPM leads Momentum by 46 points; JPM leads Risk Resilience by 30 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, AXSM or JPM?

Analyst price targets imply +83.6% upside for AXSM and +7.8% for JPM, so the Street currently favors AXSM. That points the opposite way to the AIQ Score, which favors JPM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, AXSM or JPM?

AXSM is the better-valued of the two on the peer-relative Value factor. AXSM on the peer-relative Value factor, by 55 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, AXSM or JPM?

AXSM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, AXSM or JPM?

JPM on the Momentum factor, by 46 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, AXSM or JPM?

JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 30 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is AXSM more profitable than JPM?

The profitability evidence is mixed: gross margin 93.2% vs 63.2%; operating margin -17.7% vs 28.2%; ttm roe -12.2% vs 4.1%. AXSM leads on one measure and JPM on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is JPM's lead over AXSM getting stronger or weaker?

JPM lead: Strengthening — the AIQ differential moved from 12 to 18 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the AXSM vs JPM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AXSM closes the Momentum gap — currently 46 points behind, the largest single contributor to JPM's edge; AXSM's Death Cross Active resolves — a bearish trend rule currently active against it; JPM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about AXSM and JPM?

AXSM: 1 bullish / 2 bearish / 1 neutral, conflicted. JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AXSM is Death Cross Active (bearish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).

Compare AXSM and JPM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.